United Kingdom Continuous Glucose Monitoring Devices Market Insight
United Kingdom Continuous Glucose Monitoring Devices Market is growing at an 15.85% CAGR, driven by rising diabetes prevalence, wearable technology advancements, NHS reimbursement expansion
United Kingdom Continuous Glucose Monitoring Devices Market Insights Forecasts to 2035
- The United Kingdom Continuous Glucose Monitoring Devices Market Size Was Estimated at USD 614.7 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 15.85% from 2025 to 2035
- The United Kingdom Continuous Glucose Monitoring Devices Market Size is Expected to Reach USD 2677.5 Million by 2035
Notable Insights for United Kingdom Continuous Glucose Monitoring Devices Market
- By component, sensors dominated, accounting for approximately 68% share in 2024, driven by recurring replacement demand and technological advancements.
- By device type, real-time continuous glucose monitoring systems held approximately 75% share, supported by increasing preference for real-time diabetes management solutions.
- Approximately 4.8 million people in the UK are living with diabetes, significantly increasing demand for advanced glucose monitoring technologies and wearable devices.
- Around 56% of Type 1 diabetes patients in the UK are estimated to use CGM systems, supported by NHS reimbursement and improved accessibility initiatives.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Continuous Glucose Monitoring Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Continuous Glucose Monitoring Devices Market
- Abbott Laboratories
- Dexcom
- Medtronic
- Roche
- Senseonics
- Ypsomed
- Novo Nordisk
- Ascensia Diabetes Care
- Others
Recent Developments:
- In April 2026: Dexcom accelerated UK transition from G6 to G7 and G7 15-day sensors, while expanding direct smartwatch connectivity for improved continuous glucose monitoring accessibility and convenience.
- In May 2025: Yuwell launched the Anytime CT3 CGM in the UK, featuring a rechargeable two-year transmitter and reducing continuous glucose monitoring costs by over 35% versus competitors.
Market Segmentation:
United Kingdom Continuous Glucose Monitoring Devices Market, By Component
- Sensors
- Transmitters
- Receivers
United Kingdom Continuous Glucose Monitoring Devices Market, By Device Type
- Real-Time CGM
- Intermittently Scanned CGM
United Kingdom Continuous Glucose Monitoring Devices Market, By End User
- Hospitals & Clinics
- Home Care Settings
- Diagnostic Centers
United Kingdom Continuous Glucose Monitoring Devices Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
Expert Views:
The UK Continuous Glucose Monitoring Devices Market is expected to witness rapid growth due to increasing diabetes prevalence, expanding NHS reimbursement programs, and growing preference for wearable health technologies. Experts emphasize that AI-enabled CGM systems and non-invasive glucose monitoring innovations will continue transforming diabetes management across the country. Advancements in predictive analytics, smartphone integration, and real-time glucose tracking are anticipated to improve patient outcomes, strengthen remote healthcare adoption, and support substantial market expansion through 2035.